Not applicableStudy completedNCT04150328What this trial is testingLenalidomide Monotherapy in R/R DLBCLWho this might be right forDiffuse Large B Cell Lymphoma MorphoSys AG 490
Early research (Phase 1)Ended earlyNCT03103971What this trial is testingHuJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic LeukemiaWho this might be right forRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell Lymphoma+14 more Fred Hutchinson Cancer Center 55
Early research (Phase 1)Ended earlyNCT01088763What this trial is testingGamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell LeukemiaWho this might be right forChildhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Germinoma+43 more National Cancer Institute (NCI) 129
Early research (Phase 1)WithdrawnNCT02532192What this trial is testingA Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell LymphomaWho this might be right forLymphoma M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00022581What this trial is testingThalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forRecurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Grade 3 Follicular Lymphoma+1 more National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Looking for participantsNCT06213636What this trial is testingFourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).Who this might be right forAcute Lymphoblastic Leukemia, Adult B-CellAcute Lymphoblastic Leukemia, in RelapseNon-Hodgkin Lymphoma, B-cell+4 more Essen Biotech 75
Testing effectiveness (Phase 2)WithdrawnNCT01101412What this trial is testingAntimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With MalignanciesWho this might be right forChronic Myeloproliferative DisordersInfectionLeukemia+6 more M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT04317066What this trial is testingPembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-A33/KEYNOTE-A33)Who this might be right forLymphoma, B-Cell Merck Sharp & Dohme LLC 7
Early research (Phase 1)Looking for participantsNCT06914037What this trial is testingA Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological MalignanciesWho this might be right forPeripheral T-cell LymphomaCutaneous T-cell Lymphoma (CTCL)NHL (Non-Hodgkin Lymphoma) Tianjin Medical University Cancer Institute and Hospital 24
Not applicableStudy completedNCT00301301What this trial is testingA Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)Who this might be right forNon-Hodgkins Lymphoma Royal Marsden NHS Foundation Trust 39
Very early researchLooking for participantsNCT06976437What this trial is testingA Clinical Study of Allogeneic CD19/BCMA CAR-T Cells for the Treatment of R/R B-cell Malignant TumorsWho this might be right forB Cell LymphomaMultiple Myeloma YANRU WANG 21
Testing effectiveness (Phase 2)Ended earlyNCT05265975What this trial is testingATG-010 in Combination With Lenalidomide and Rituximab (R2) in Adults With DLBCL and iNHLWho this might be right forDiffuse Large B-cell LymphomaIndolent Non-Hodgkin Lymphoma Antengene Corporation 54
Testing effectiveness (Phase 2)Study completedNCT04298879What this trial is testingIBI376 in Patients With Relapsed or Refractory Follicular Lymphoma/Marginal Zone LymphomaWho this might be right forIndolent Non-hodgkin Lymphoma Innovent Biologics (Suzhou) Co. Ltd. 81
Testing effectiveness (Phase 2)Study completedNCT00884286What this trial is testingMulticenter Trial to Treat Patients With Relapsed/Refractory Aggressive Non Hodgkin LymphomaWho this might be right forLeukemiaLymphoma PharmaMar 67
Early research (Phase 1)Looking for participantsNCT06176690What this trial is testingConstitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive LymphomasWho this might be right forCD30-Positive Diffuse Large B-Cell LymphomaAnaplastic Large Cell Lymphoma, T Cell and Null Cell TypeAnaplastic Large Cell Lymphoma, ALK-Positive+4 more Baylor College of Medicine 90
Early research (Phase 1)Study completedNCT00569283What this trial is testingDonor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow TransplantWho this might be right forCancer Asan Medical Center 18
Early research (Phase 1)Study completedNCT00334438What this trial is testingBortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's LymphomaWho this might be right forLymphoma UNC Lineberger Comprehensive Cancer Center 12
Very early researchLooking for participantsNCT04532281What this trial is testingMurine CD19 CAR-T Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological MalignanciesWho this might be right forAcute Lymphoblastic LeukemiaNon-Hodgkin Lymphoma of Soft Tissue Zhejiang University 120
Testing effectiveness (Phase 2)Ended earlyNCT04305444What this trial is testingStudy of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's LymphomasWho this might be right forRelapsed Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic LeukemiaDiffuse Large B Cell Lymphoma+2 more Zhejiang DTRM Biopharma 55
Early research (Phase 1)Study completedNCT03527147What this trial is testingPlatform Study for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (PRISM Study)Who this might be right forNHLDLBCLNon-hodgkin's Lymphoma+1 more Acerta Pharma BV 30